RecruitingNot ApplicableNCT06360627
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Sponsor
University of Zurich
Enrollment
100 participants
Start Date
Feb 20, 2023
Study Type
INTERVENTIONAL
Conditions
Summary
Evaluation of ultra low dose protocols and Iomeron 400 contrast in PCD-CT
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether ultra-low-dose CT scans — which use much less radiation than standard CT — combined with a specific contrast agent (Iomeron 400) can produce high-quality images using new photon-counting detector CT (PCD-CT) technology. The goal is to detect lung nodules and pneumonia with less radiation exposure.
**You may be eligible if...**
- You are 18 or older
- You have been referred for a CT scan to evaluate a lung nodule or check for pneumonia
- Your BMI is 30 or below
**You may NOT be eligible if...**
- You are under 18 years old
- Your BMI is over 30
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
RADIATIONComputed Tomography
Computed Tomography CHEST
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06360627
Related Trials
Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
NCT000061501 location
Standard Follow-up Program (SFP) for Lung Cancer Patients Treated With Radiotherapy or Chemoradiation
NCT024217181 location
Molecular Analysis of Endoscopic Cytology Samples Supernatant in Pulmonary Nodules
NCT053069121 location
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
NCT060606139 locations
Metabolic Biomarkers in Thoracic Cancers
NCT020958081 location